AACR Annual Meeting 2019: NCI Leaders Praise Progress and Collaboration
Two of the nation’s preeminent leaders in cancer research and policy took the stage Sunday morning at the Opening...
Two of the nation’s preeminent leaders in cancer research and policy took the stage Sunday morning at the Opening...
Last Friday, March 8, 2019, marked another milestone in immuno-oncology: The U.S. Food and Drug Administration (FDA) announced the...
In the final weeks of 2018, the U.S. Food and Drug Administration (FDA) announced three approvals of anticancer therapeutics....
The past two weeks have seen a flurry of U.S. Food and Drug Administration (FDA) approvals of new treatments...
On Monday, the U.S. Food and Drug Administration (FDA) announced the highly anticipated approval of the molecularly targeted therapeutic...
During the early part of November, we saw the U.S. Food and Drug Administration (FDA) approve a new molecularly...
In the midst of Breast Cancer Awareness Month, the US. Food and Drug Administration (FDA) provided good news for...
Last week saw a flurry of new anticancer therapeutics approved by the U.S. Food and Drug Administration (FDA) for...
Cancer treatments have been, and continue to be in most cases, based on the organ site where the tumor...
In 2017, electronic cigarettes (e-cigarettes) were the most commonly used tobacco product among high and middle school students. Many...